Radial Compression Devices MarketSize and Trends

Global radial compression devices market is estimated to be valued at US$ 261.1 million in 2023 and is expected to exhibit a CAGR of 8.3% during the forecast period (2023-2030).

Global Radial Compression Devices Market – Driver

Increasing launch of New Products, Growing adoption of radial access procedures

For instance, in November 2022, according to Merit Medical Systems, Inc., a developer and marketer of proprietary disposable medical devices, announced U.S. commercial of PreludeSync EZ radial compression device. The company designed it to prevent the bleeding after radial artery access procedure, PreludeSYNC EZ assists in the prevention of bleeding following radial artery access procedures.

Increasing Prevalence of Cardiovascular Diseases, Technological Advancements in Radial Compression Devices, and Rising Demand for Minimally Invasive Procedures

Advancement in the technologies with the efficient radial compression devices is expected to drive the radial compression device market. The market is expected to witness growth, owing to rising use of radial access techniques that provide patients quick movement and lower the risk of problems. For instance, in March 2022, an article is published in American Heart Association, the article study aimed to determine trends in radial access use over time, with increasing use of radial access is driven by new invasive and interventional cardiologists (operators) or existing operators changing their practice.

Global Radial Compression Device Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

The impact of COVID-19 on the cardiovascular system in general, which may indirectly affect the radial artery. For example, COVID-19 causes inflammation in the body that can lead to cardiovascular complications such as heart attacks and abnormal heart rhythms. COVID-19 patients with coronary artery calcification (CAC) requires intubation, and can die. For instance, in October 2020, an article published by Elsevier in the journal of clinical imaging titled,” Coronary artery calcification in COVID-19 patients: An imaging biomarker for adverse clinical outcomes”, studied the effect of COVID-19 on the coronary arteries.